MAGE-D2 antibody
Principal name
MAGE-D2 antibody
Alternative names for MAGE-D2 antibody
Melanoma-associated antigen D2, MAGED2, BCG1, Breast cancer-associated gene 1 protein, 11B6, Hepatocellular carcinoma-associated protein JCL-1
Gene ID
10916 (MAGED2)
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection))
Background of MAGE-D2 antibody
- Kit Component:
- - KN201748G1, MAGED2 gRNA vector 1 in pCas-Guide vector
- KN201748G2, MAGED2 gRNA vector 2 in pCas-Guide vector
- KN201748D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Detection limit for recombinant GST tagged MAGED2 is approximately 1ng/ml as a capture antibody.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with MAGED2 polyclonal antibody ( Cat # PAB4757 ) , which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry ; clinical relevance has not been evaluated. HC = hepatocarcinoma.
The MAGED2 polyclonal antibody ( Cat # PAB4757 ) is used in Western blot to detect MAGED2 in A-549 cell lysate.
MAGED2 monoclonal antibody (M03), clone 1B5. Western Blot analysis of MAGED2 expression in MCF-7 ( Cat # L046V1 ).
Western Blot analysis of MAGED2 expression in transfected 293T cell line (H00010916-T02) by MAGED2 MaxPab polyclonal antibody.Lane 1: MAGED2 transfected lysate(65.00 KDa).Lane 2: Non-transfected lysate.
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining.
The anti-MAGED2 C-term Antibody is used in Western blot to detect MAGED2 in A549 lysate.
Human Brain; WB Suggested Anti-MAGED2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human brain; MAGED2 antibody - N-terminal region (ARP59887_P050) in Human Brain cells using Western Blot
WB Suggested Anti-MAGED2 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human brain
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP13142PU-N | MAGE-D2 (C-term) antibody |
||||||
 |
Rabbit | Ig | Purified | Hu | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301748 | MAGE-D2 (transcript variant 1) |
||||
| Recombinant protein of human melanoma antigen family D, 2 (MAGED2), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP314066 | MAGE-D2 (transcript variant 3) |
||||
| Recombinant protein of human melanoma antigen family D, 2 (MAGED2), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP319260 | MAGE-D2 (transcript variant 2) |
||||
| Recombinant protein of human melanoma antigen family D, 2 (MAGED2), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||